Target Price | $499.18 |
Price | $414.93 |
Potential | 20.31% |
Number of Estimates | 11 |
11 Analysts have issued a price target IDEXX Laboratories 2025 . The average IDEXX Laboratories target price is $499.18. This is 20.31% higher than the current stock price. The highest price target is $566.00 36.41% , the lowest is $435.00 4.84% . | |
A rating was issued by 15 analysts: 8 Analysts recommend IDEXX Laboratories to buy, 7 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the IDEXX Laboratories stock has an average upside potential 2025 of 20.31% . Most analysts recommend the IDEXX Laboratories stock at Purchase. |
11 Analysts have issued a sales forecast IDEXX Laboratories 2024 . The average IDEXX Laboratories sales estimate is $3.9b . This is 0.88% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $3.9b 1.19% , the lowest is $3.9b 0.71% .
This results in the following potential growth metrics:
2023 | $3.7b | 8.72% |
---|---|---|
2024 | $3.9b | 5.95% |
2025 | $4.2b | 7.21% |
2026 | $4.5b | 8.58% |
2027 | $4.9b | 9.54% |
2028 | $5.4b | 9.04% |
8 Analysts have issued an IDEXX Laboratories EBITDA forecast 2024. The average IDEXX Laboratories EBITDA estimate is $1.3b . This is 4.22% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $1.4b 11.32% , the lowest is $1.2b 0.25% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | $1.2b | 22.17% |
---|---|---|
2024 | $1.3b | 6.87% |
2025 | $1.4b | 10.37% |
2026 | $1.5b | 8.53% |
2027 | $1.7b | 10.76% |
2028 | $1.9b | 9.71% |
2023 | 32.98% | 12.37% |
---|---|---|
2024 | 33.27% | 0.88% |
2025 | 34.25% | 2.95% |
2026 | 34.23% | 0.06% |
2027 | 34.61% | 1.11% |
2028 | 34.82% | 0.61% |
12 IDEXX Laboratories Analysts have issued a net profit forecast 2024. The average IDEXX Laboratories net profit estimate is $858m . This is 0.93% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $864m 1.64% , the lowest is $853m 0.39% .
This results in the following potential growth metrics and future Net Margins:
2023 | $825m | 25.28% |
---|---|---|
2024 | $858m | 3.94% |
2025 | $983m | 14.62% |
2026 | $1.1b | 13.23% |
2027 | $1.3b | 14.09% |
2028 | $1.4b | 9.35% |
2023 | 22.54% | 15.23% |
---|---|---|
2024 | 22.12% | 1.88% |
2025 | 23.64% | 6.87% |
2026 | 24.66% | 4.31% |
2027 | 25.68% | 4.14% |
2028 | 25.75% | 0.27% |
12 Analysts have issued a IDEXX Laboratories forecast for earnings per share. The average IDEXX Laboratories <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $10.46 . This is 0.97% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $10.53 1.64% , the lowest is $10.40 0.39% .
This results in the following potential growth metrics and future valuations:
2023 | $10.06 | 25.28% |
---|---|---|
2024 | $10.46 | 3.98% |
2025 | $11.98 | 14.53% |
2026 | $13.57 | 13.27% |
2027 | $15.48 | 14.08% |
2028 | $16.93 | 9.37% |
Current | 40.03 | 29.19% |
---|---|---|
2024 | 39.68 | 0.87% |
2025 | 34.62 | 12.75% |
2026 | 30.58 | 11.67% |
2027 | 26.80 | 12.36% |
2028 | 24.51 | 8.54% |
Based on analysts' sales estimates for 2024, the IDEXX Laboratories stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 8.94 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 8.76 .
This results in the following potential growth metrics and future valuations:
Current | 9.02 | 30.88% |
---|---|---|
2024 | 8.94 | 0.92% |
2025 | 8.34 | 6.73% |
2026 | 7.68 | 7.90% |
2027 | 7.01 | 8.71% |
2028 | 6.43 | 8.29% |
Current | 8.84 | 31.09% |
---|---|---|
2024 | 8.76 | 0.88% |
2025 | 8.17 | 6.73% |
2026 | 7.52 | 7.90% |
2027 | 6.87 | 8.71% |
2028 | 6.30 | 8.29% |
IDEXX Laboratories...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.